125 related articles for article (PubMed ID: 34399207)
21. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
[TBL] [Abstract][Full Text] [Related]
22. I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films.
Poder J; Corde S
Med Phys; 2013 Dec; 40(12):121709. PubMed ID: 24320495
[TBL] [Abstract][Full Text] [Related]
23. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
Lesperance M; Inglis-Whalen M; Thomson RM
Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
[TBL] [Abstract][Full Text] [Related]
24. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
[TBL] [Abstract][Full Text] [Related]
25. Application of a directional palladium-103 brachytherapy device on a curved surface.
Veltchev I; Price R; Chen X; Howell K; Meyer J; Ma CM
Med Phys; 2019 Apr; 46(4):1905-1913. PubMed ID: 30734318
[TBL] [Abstract][Full Text] [Related]
26. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
Miras H; Terrón JA; Lallena AM
Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
[TBL] [Abstract][Full Text] [Related]
27. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
[TBL] [Abstract][Full Text] [Related]
28. Monte Carlo dosimetry modeling of focused kV x-ray radiotherapy of eye diseases with potential nanoparticle dose enhancement.
Yan H; Ma X; Sun W; Mendez S; Stryker S; Starr-Baier S; Delliturri G; Zhu D; Nath R; Chen Z; Roberts K; MacDonald CA; Liu W
Med Phys; 2018 Oct; 45(10):4720-4733. PubMed ID: 30133705
[TBL] [Abstract][Full Text] [Related]
29. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
[TBL] [Abstract][Full Text] [Related]
30. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
31. Correction factors for source strength determination in HDR brachytherapy using the in-phantom method.
Ubrich F; Wulff J; Engenhart-Cabillic R; Zink K
Z Med Phys; 2014 May; 24(2):138-52. PubMed ID: 24021956
[TBL] [Abstract][Full Text] [Related]
32. On the actual state of industrial quality assurance procedures with regard to (106)Ru ophthalmic plaques.
Kaulich TW; Zurheide J; Haug T; Budach W; Nüsslin F; Bamberg M
Strahlenther Onkol; 2004 Jun; 180(6):358-64. PubMed ID: 15175870
[TBL] [Abstract][Full Text] [Related]
33. Hydrogen nanobubbles: A novel approach toward radio-sensitization agents.
Hashemi S; Aghamiri SM; Siavashpour Z; Kahani M; Zaidi H; Jaberi R
Med Phys; 2023 Oct; 50(10):6589-6599. PubMed ID: 37278345
[TBL] [Abstract][Full Text] [Related]
34. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
35. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
Bannon EA; Yang Y; Rivard MJ
Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric characterization of a novel
Rogers B; Lawrence J; Chmura J; Ehler E; Ferreira C
Phys Med; 2020 Apr; 72():52-59. PubMed ID: 32200298
[TBL] [Abstract][Full Text] [Related]
37. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
Asadi S; Vaez-Zadeh M; Vahidian M; Marghchouei M; Masoudi SF
J Appl Clin Med Phys; 2016 May; 17(3):90-99. PubMed ID: 27167265
[TBL] [Abstract][Full Text] [Related]
38. Novel intraocular shielding device for eye plaque brachytherapy using magnetite nanoparticles: A proof-of-concept study using radiochromic film and Monte Carlo simulations.
Oare CC; Dailey JP; Gerbi B; Ferreira C
Brachytherapy; 2023; 22(6):769-778. PubMed ID: 37718143
[TBL] [Abstract][Full Text] [Related]
39. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
Mostafa L; Rachid K; Ahmed SM
Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
[TBL] [Abstract][Full Text] [Related]
40. Data on estimations of relative dose rates along central axis of symmetric and asymmetric
Paiva E
Data Brief; 2021 Feb; 34():106620. PubMed ID: 33365366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
